uu.seUppsala universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Process development for the production of a therapeutic Affibody® Molecule
Uppsala universitet, Teknisk-naturvetenskapliga vetenskapsområdet, Biologiska sektionen, Institutionen för biologisk grundutbildning.
2014 (Engelska)Självständigt arbete på avancerad nivå (masterexamen), 20 poäng / 30 hpStudentuppsats (Examensarbete)Alternativ titel
Processutveckling för att tillverka en Affibody®-molekyl avsedd för cancerterapi (Svenska)
Abstract [en]

Recently HER3, member of the epidermal growth factor receptor family (EGFR), has been found to play a crucial role in the development of resistance towards inhibitors that are given to patients with HER1- and HER2-driven cancers. As HER3 is up-regulated or over-activated in several types of human cancers, it is of outmost importance that new innovative drugs target its oncologic activity.

The Affibody® Molecule Z08698 inhibits the heregulin induced signalling of HER3 with high affinity (KD~50 pM). As the Affibody® Molecule is small, has high solubility and outstanding folding kinetics, an effective penetration of tumour tissue is suggested together with a rationalized manufacturing process. Further coupling to an albumin binding domain (ABD) expands the plasma half-life of the molecule, hence increasing the molecule's potential of serving as a therapeutic.

A process development for production of Z08698-VDGS-ABD094 has been established, where the molecule is efficiently produced in the E. coli host strain BL21(DE3), through a T7 based expression system. Cultivations were performed with a fed-batch fermentation process and the conditions were further optimized in order to obtain highest expression, while avoiding undesirable modifications like gluconoylations. By employing Design of experiments in combination with multivariate data analysis, a production process resulting in ~3.5 g product/ l culture could be verified. Moreover, thermolysis was evaluated as a suitable method for cell disruption, enabling an easy and cost-effective manufacturing process of the ABD fused Affibody® Molecule.

Ort, förlag, år, upplaga, sidor
2014. , s. 60
Nyckelord [en]
Affibody® Molecule, HER3, EGFR, HER2, cancer therapy, process development, DOE, multivariate data analysis, E. coli, ABD, plasma half-life, thermolysis, fed-batch, gluconoylation, BL21(DE3), T7 expression system
Nationell ämneskategori
Teknik och teknologier
Identifikatorer
URN: urn:nbn:se:uu:diva-218861OAI: oai:DiVA.org:uu-218861DiVA, id: diva2:697657
Externt samarbete
Affibody AB
Utbildningsprogram
Civilingenjörsprogrammet i molekylär bioteknik
Handledare
Examinatorer
Tillgänglig från: 2014-02-20 Skapad: 2014-02-18 Senast uppdaterad: 2014-02-20Bibliografiskt granskad

Open Access i DiVA

fulltext(3179 kB)600 nedladdningar
Filinformation
Filnamn FULLTEXT01.pdfFilstorlek 3179 kBChecksumma SHA-512
6a208423a9d97219df4ba87fac7c75ba5a54899a2b4ceba8547cb3f35f0548d6a19f03b7f6b2a0c391b5e48b5b63321b488826aff9b0deb277598087f3035362
Typ fulltextMimetyp application/pdf

Av organisationen
Institutionen för biologisk grundutbildning
Teknik och teknologier

Sök vidare utanför DiVA

GoogleGoogle Scholar
Totalt: 600 nedladdningar
Antalet nedladdningar är summan av nedladdningar för alla fulltexter. Det kan inkludera t.ex tidigare versioner som nu inte längre är tillgängliga.

urn-nbn

Altmetricpoäng

urn-nbn
Totalt: 669 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf